Concurrent Coxsackie Virus A6 Infection and Kawasaki Disease.
Matsukura H, Majima S, Sakuma T.
Indian Pediatr. 2022 Aug 15;59(8):656-657. doi: 10.1007/s13312-022-2583-5.
Adult heart disease due to the Coxsackie virus B infection.
Sainani GS, Krompotic E, Slodki SJ.
Medicine (Baltimore). 1968 Mar;47(2):133-47. doi: 10.1097/00005792-196803000-00003.
Retinopathy Associated With Coxsackie B Virus Infection.
Hanif A, Thanos A.
JAMA Ophthalmol. 2024 Jan 1;142(1):e234721. doi: 10.1001/jamaophthalmol.2023.4721. Epub 2024 Jan 18.
Coxsackie virus infection in association with heart affection in man.
Petrovicová A, Cervenka J, Egnerová A.
J Hyg Epidemiol Microbiol Immunol. 1987;31(3):251-7.
Coxsackie virus infection in acute myocardial infarction.
Nicholls AC, Thomas M.
Lancet. 1977 Apr 23;1(8017):883-4. doi: 10.1016/s0140-6736(77)91203-x.
Coxsackie B virus infection and onset of childhood diabetes.
Clements GB, Galbraith DN, Taylor KW.
Lancet. 1995 Jul 22;346(8969):221-3. doi: 10.1016/s0140-6736(95)91270-3.
Human Gut-On-A-Chip Supports Polarized Infection of Coxsackie B1 Virus In Vitro.
Villenave R, Wales SQ, Hamkins-Indik T, Papafragkou E, Weaver JC, Ferrante TC, Bahinski A, Elkins CA, Kulka M, Ingber DE.
PLoS One. 2017 Feb 1;12(2):e0169412. doi: 10.1371/journal.pone.0169412. eCollection 2017.
Umifenovir effectively inhibits IL-10 dependent persistent Coxsackie B4 virus infection.
Zhang S, Zhi C, Li H, Huang D, Fan Q, Cui J, Liang C.
Antiviral Res. 2017 May;141:165-173. doi: 10.1016/j.antiviral.2017.02.018. Epub 2017 Mar 2.
Rhabdomyolysis following recent severe coxsackie virus infection in patient with chronic renal failure: one case report and a review of the literature.
Wang YM, Zhang Y, Ye ZB.
Ren Fail. 2006;28(1):89-93. doi: 10.1080/08860220500461310.
Antiviral treatment of Coxsackie B virus infection in human pancreatic islets.
Berg AK, Olsson A, Korsgren O, Frisk G.
Antiviral Res. 2007 Apr;74(1):65-71. doi: 10.1016/j.antiviral.2006.12.001. Epub 2006 Dec 29.
